Intratumoral CD8+ T cells with a tissue-resident memory phenotype mediate local immunity and immune checkpoint responses in breast cancer
Balaji Virassamy(Peter MacCallum Cancer Centre), Sherene Loi(The University of Melbourne), Ann Byrne(Peter MacCallum Cancer Centre), Julia Teply‐Szymanski(German Breast group), Kylie Clarke(Peter MacCallum Cancer Centre), Charles Swanton(Cancer Research UK), Sneha Sant(Peter MacCallum Cancer Centre), Olivia Lucas(CRUK Lung Cancer Centre of Excellence), Luke C. Gandolfo(The University of Melbourne), Zhi L. Teo(The University of Melbourne), Carsten Denkert(Philipps University of Marburg), Laura K. Mackay(Peter Doherty Institute), Paul J. Neeson(The University of Melbourne), Karsten E. Weber(German Breast group), David Freestone(The University of Melbourne), Stephen J. Luen(Peter MacCallum Cancer Centre), Phillip K. Darcy(The University of Melbourne), Emmaline Brown(Peter MacCallum Cancer Centre), Franco Caramia(The University of Melbourne), Bianca von Scheidt(Peter MacCallum Cancer Centre), Sibylle Loibl, Peter Savas(Peter MacCallum Cancer Centre), Ran Li(Peter MacCallum Cancer Centre), Terence P. Speed(The University of Melbourne), Jianan Wang(Second Affiliated Hospital of Zhejiang University), Susan N. Christo(The University of Melbourne)
Cited by 218
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer
|New England Journal of Medicine|2015|1.6k